with Elma, ACR are not cashflow positive, Almost, but no. Will Dapsone 5% be the one that makes ACR cashflow positive? If so then every ANDA launch in the US after this is all upside. So pleased with this news. ACR has turned the corner for the better. With more cash behind them, a ramping up of the pipeline will grow much quicker. Maybe a Snowball effect once the shackles are off. The next bit of good new will hopefully be that Dapsone 7.5% has been given FDA approval. A drug with 100's of millions in yearly US sales. Jet
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.7¢ |
Change
-0.001(5.56%) |
Mkt cap ! $7.366M | |||
| Open | High | Low | Value | Volume |
| 2.0¢ | 2.0¢ | 1.7¢ | $5.019K | 259.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 845816 | 1.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.8¢ | 105334 | 1 |
View Market Depth
| Last trade - 10.02am 31/07/2025 (20 minute delay) ? |
| ACR (ASX) Chart |